Scientists Explore CBD as Potential Preventative COVID-19 Therapy
by Ana Charvelle
A recently published Preprints study found that the cannabinoids could help to down-regulate the production of proteins that are key in spreading the coronavirus among humans.
(High CBD) Cannabis Sativa may be a way to help prevent the body from acquiring the COVID-19 virus, according to this research study.
Two Canadian research Scientists released this information in the June 27-2020 April issue of the online medical journal Preprints.
Researchers, Olga and Igor Kovalchuck have been developing and testing cannabis strains that could potentially fight COVID-19.
In the case of Kovalchucks work, (CBD) cannabis would be used to decrease the level of ACE2 gene expression, essentially temporarily closing the doors to the virus.
“Cannabis CBD, especially one high in anti-inflammatory cannabidiol (CBD- C) Sativa, has been proposed to modulate gene expression, inflammation and harbor anti-cancer properties,” the study says.
“Working under the Health Canada research licensee, we have over 800 new Cannabis Sativa lines and extracts and hypothesized that high-CBD sativa extracts may be used to modulate ACE2 expression in COVID-19 target tissues.
Right now, it’s still a theory, not a confirmed fact. However, it offers hope for the future. They are looking to develop High CBD sativa mouthwash, and throat gargle. Given the current dire epidemiological situation, every possible therapeutic opportunity and avenue must be considered.
